Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension | Zendy

Maurizio Pompili | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension

Author(s) -

Maurizio Pompili

Publication year - 2010

Publication title -

neuropsychiatric disease and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.819

H-Index - 67

eISSN - 1178-2021

pISSN - 1176-6328

DOI - 10.2147/ndt.s12044

Subject(s) - suicidal ideation , medicine , schizophrenia (object oriented programming) , clinical global impression , psychiatry , global assessment of functioning , positive and negative syndrome scale , suicide attempt , poison control , suicide prevention , clinical psychology , psychosis , medical emergency , alternative medicine , pathology , placebo

Suicide is a major problem in schizophrenia, estimated to affect 9%-13% of patients. About 25% of schizophrenic patients make at least one suicide attempt in their lifetime. Current outcome measures do not address this problem, even though it affects quality of life and patient safety. The aim of this study was to assess suicidality in long-term clinically improved schizophrenia patients who were treated in a nongovernmental psychiatric treatment centre in Mumbai, India.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research